NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 9.78% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 7.54% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.94% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.04% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.03% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.34% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.07% |
SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 3.62% |
MDT | Medtronic PLC | Healthcare | Medical Devices | 3.48% |
SYK | Stryker Corporation | Healthcare | Medical Devices | 3.48% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.22% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.17% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.12% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.91% |
0QIU | Novo Nordisk A/S Class B | 2.49% | ||
CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.10% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.02% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.96% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.74% |